China Gemstone Capital (Beijing) Co., Ltd is a leading private equity investment firm in China's pharmaceutical and healthcare markets.  Gemstone Capital specialise in Venture Capital, M&A, Fundraising, Financial Advisory to provide diversified clients with a broad range of financial services. So far Gemstone Capital have signed over 20 billion buyout fund and have about 1 billion VC fund under management. With abundant resources,  Gemstone Capital have undertaken over 400 due diligence cases and have formed long-term partnership with over 1000 companies.